Page 244 - Remedial Andrology

1510. Ferlin, A., et al. Contemporary genetics-based diagnostics of male infertility. Expert Rev Mol Diagn,
2019. 19: 623.
https://pubmed.ncbi.nlm.nih.gov/31215260
1511. Nguyen, M.H., et al. Balanced complex chromosome rearrangement in male infertility: case report
and literature review. Andrologia, 2015. 47: 178.
https://onlinelibrary.wiley.com/doi/abs/10.1111/and.12245
1512. Siffroi, J.P., et al. Assisted reproductive technology and complex chromosomal rearrangements: the
limits of ICSI. Mol Hum Reprod, 1997. 3: 847.
https://pubmed.ncbi.nlm.nih.gov/9395262
1513. De Boeck, K. Cystic fibrosis in the year 2020: a disease with a new face. Acta Paediatr, 2020.
https://pubmed.ncbi.nlm.nih.gov/31899933
1514. McBride, J.A., et al. Sperm retrieval and intracytoplasmic sperm injection outcomes in men with
cystic fibrosis disease versus congenital bilateral absence of the vas deferens. Asian J Androl, 2020.
https://pubmed.ncbi.nlm.nih.gov/32930103
1515. Donat, R., et al. The incidence of cystic fibrosis gene mutations in patients with congenital bilateral
absence of the vas deferens in Scotland. Br J Urol, 1997. 79: 74.
https://pubmed.ncbi.nlm.nih.gov/9043501
1516. Practice Committee of the American Society for Reproductive, M. Diagnostic evaluation of the
infertile male: a committee opinion. Fertil Steril, 2015. 103: e18.
https://pubmed.ncbi.nlm.nih.gov/25597249
1517. Oates, R. Evaluation of the azoospermic male. Asian J Androl, 2012. 14: 82.
https://pubmed.ncbi.nlm.nih.gov/22179510
1518. Daudin, M., et al. Congenital bilateral absence of the vas deferens: clinical characteristics, biological
parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications
for genetic counseling. Fertil Steril, 2000. 74: 1164.
https://pubmed.ncbi.nlm.nih.gov/11119745
1519. Chillon, M., et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas
deferens. N Engl J Med, 1995. 332: 1475.
https://pubmed.ncbi.nlm.nih.gov/7739684
1520. De Braekeleer, M., et al. Mutations in the cystic fibrosis gene in men with congenital bilateral
absence of the vas deferens. Mol Hum Reprod, 1996. 2: 669.
https://pubmed.ncbi.nlm.nih.gov/9239681
1521. Nathanson, K.L., et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am
J Hum Genet, 2005. 77: 1034.
https://pubmed.ncbi.nlm.nih.gov/16380914
1522. Krausz, C., et al. Genetic risk factors in male infertility. Arch Androl, 2007. 53: 125.
https://pubmed.ncbi.nlm.nih.gov/17612870
1523. Augarten, A., et al. Congenital bilateral absence of vas deferens in the absence of cystic fibrosis.
Lancet, 1994. 344: 1473.
https://pubmed.ncbi.nlm.nih.gov/7968122
1524. Schlegel, P.N., et al. Urogenital anomalies in men with congenital absence of the vas deferens.
J Urol, 1996. 155: 1644.
https://pubmed.ncbi.nlm.nih.gov/8627844
1525. Drake, M.J., et al. Absent vas deferens and ipsilateral multicystic dysplastic kidney in a child. Br
J Urol, 1996. 77: 756.
https://pubmed.ncbi.nlm.nih.gov/8689131
1526. Vogt, P.H., et al. Human Y chromosome azoospermia factors (AZF) mapped to different subregions
in Yq11. Hum Mol Genet, 1996. 5: 933.
https://pubmed.ncbi.nlm.nih.gov/8817327
1527. Krausz, C., et al. Spermatogenic failure and the Y chromosome. Hum Genet, 2017. 136: 637.
https://pubmed.ncbi.nlm.nih.gov/28456834
1528. Skaletsky, H., et al. The male-specific region of the human Y chromosome is a mosaic of discrete
sequence classes. Nature, 2003. 423: 825.
https://pubmed.ncbi.nlm.nih.gov/12815422
1529. Tyler-Smith, C., et al. The will-o’-the-wisp of genetics--hunting for the azoospermia factor gene.
N Engl J Med, 2009. 360: 925.
https://pubmed.ncbi.nlm.nih.gov/19246366
1530. Stouffs, K., et al. Are AZFb deletions always incompatible with sperm production? Andrology, 2017.
5: 691.
https://pubmed.ncbi.nlm.nih.gov/28395120

SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021 243